Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease

Abstract Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment. Of 692 patients who received mesalazine for IBD between 2014 an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Satohiro Matsumoto, Hirosato Mashima
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a50c4d8aa4dc4df286985a54519ff870
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!